Equities

Tectonic Therapeutic Inc

TECX:NMQ

Tectonic Therapeutic Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)20.04
  • Today's Change0.24 / 1.21%
  • Shares traded486.33k
  • 1 Year change+9.87%
  • Beta1.1830
Data delayed at least 15 minutes, as of Sep 20 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments9893190
Total Receivables, Net00.272.70
Total Inventory------
Prepaid expenses1.395.845.18
Other current assets, total0.851.291.70
Total current assets100100199
Property, plant & equipment, net0.433.954.13
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets00.040.07
Total assets101104204
LIABILITIES
Accounts payable0.030.383.49
Accrued expenses4.345.175.58
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total1.997.5610
Total current liabilities6.351319
Total long term debt01515
Total debt01515
Deferred income tax------
Minority interest------
Other liabilities, total00.190.03
Total liabilities6.352934
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital572565553
Retained earnings (accumulated deficit)(477)(489)(384)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity9575169
Total liabilities & shareholders' equity101104204
Total common shares outstanding3.723.663.64
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.